What is NAMSA?
Founded in 1967 and headquartered in Northwood, Ohio, NAMSA operates as a critical partner for medical device manufacturers. The company distinguishes itself through an integrated service architecture that combines clinical research, regulatory expertise, and laboratory testing. This holistic approach allows NAMSA to accelerate the product development lifecycle, ensuring that medical technologies reach the market with both safety and efficacy profiles validated by rigorous scientific standards. As an MRO, the firm serves as a vital intermediary in the healthcare ecosystem, navigating the intricate regulatory pathways that define the medical device industry.
How much funding has NAMSA raised?
NAMSA has raised a total of $5M across 1 funding round:
Debt
$5M
Debt (2020): $5M with participation from PPP
Key Investors in NAMSA
PPP
Public-Private Partnership
What's next for NAMSA?
With the recent influx of capital, NAMSA is well-positioned to scale its enterprise-level operations and expand its global footprint. The strategic focus will likely center on enhancing its digital health capabilities and deepening its regulatory consulting expertise to address the evolving requirements of international health authorities. By prioritizing technological integration and operational efficiency, the firm aims to maintain its competitive advantage in a sector characterized by high barriers to entry and increasing demand for specialized clinical research. Future growth will be driven by the firm's ability to synthesize complex regulatory data into actionable development strategies for its diverse client base.
See full NAMSA company page
